Noriyuki Ashida

1.2k total citations
53 papers, 976 citations indexed

About

Noriyuki Ashida is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Noriyuki Ashida has authored 53 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 22 papers in Organic Chemistry and 18 papers in Molecular Biology. Recurrent topics in Noriyuki Ashida's work include HIV/AIDS drug development and treatment (24 papers), Biochemical and Molecular Research (11 papers) and Herpesvirus Infections and Treatments (10 papers). Noriyuki Ashida is often cited by papers focused on HIV/AIDS drug development and treatment (24 papers), Biochemical and Molecular Research (11 papers) and Herpesvirus Infections and Treatments (10 papers). Noriyuki Ashida collaborates with scholars based in Japan, United States and Saudi Arabia. Noriyuki Ashida's co-authors include Tomohisa Nagamatsu, Shinji Sakata, Hamed I. Ali, Haruhiko Machida, Eiichi Kodama, Hiroyuki Hayakawa, Hiroaki Mitsuya, Yuichi Yoshimura, Satoru Kohgo and Stefan G. Sarafianos and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Noriyuki Ashida

52 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Noriyuki Ashida Japan	17	418	378	326	252	178	53	976
Cheng-Kon Shih United States	13	681 1.6×	337 0.9×	348 1.1×	595 2.4×	162 0.9×	16	1.1k
Elizabeth A. Gullen United States	24	406 1.0×	713 1.9×	450 1.4×	174 0.7×	301 1.7×	51	1.6k
Kristina Campanale United States	10	250 0.6×	368 1.0×	329 1.0×	131 0.5×	52 0.3×	17	1.1k
Michel Garneau Canada	21	289 0.7×	495 1.3×	212 0.7×	100 0.4×	339 1.9×	57	1.3k
Lianhong Xu United States	18	231 0.6×	270 0.7×	378 1.2×	146 0.6×	71 0.4×	42	920
Richard A. Mueller United States	17	206 0.5×	423 1.1×	546 1.7×	100 0.4×	92 0.5×	34	1.2k
Alessandro Schipani United Kingdom	14	306 0.7×	346 0.9×	201 0.6×	126 0.5×	105 0.6×	19	948
Richard Hazen United States	20	879 2.1×	516 1.4×	441 1.4×	687 2.7×	275 1.5×	36	1.5k
Tsutomu Mimoto Japan	13	475 1.1×	427 1.1×	325 1.0×	388 1.5×	54 0.3×	20	878
Ya-Qiu Long United States	19	188 0.4×	407 1.1×	388 1.2×	149 0.6×	34 0.2×	23	818

Countries citing papers authored by Noriyuki Ashida

Since Specialization

Citations

This map shows the geographic impact of Noriyuki Ashida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriyuki Ashida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriyuki Ashida more than expected).

Fields of papers citing papers by Noriyuki Ashida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriyuki Ashida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriyuki Ashida. The network helps show where Noriyuki Ashida may publish in the future.

Co-authorship network of co-authors of Noriyuki Ashida

This figure shows the co-authorship network connecting the top 25 collaborators of Noriyuki Ashida. A scholar is included among the top collaborators of Noriyuki Ashida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriyuki Ashida. Noriyuki Ashida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mohamed, Mosaad S., Mohamed A. Elsawy, Noriyuki Ashida, et al.. (2023). Design, synthesis, and antitumor efficacy of novel 5-deazaflavin derivatives backed by kinase screening, docking, and ADME studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2220570–2220570. 4 indexed citations

Murata, Makoto, et al.. (2016). Enzyme-linked immunosorbent assay for S100A9 in the stool of rats with dextran sulfate sodium-induced colitis. Journal of Immunological Methods. 439. 44–49. 6 indexed citations

Kawasaki, Atsushi, et al.. (2013). Novel Effects of Uridine on Behavioral Changes Due to Social Isolation Stress in Mice. Food Science and Technology Research. 19(3). 455–461. 4 indexed citations

Michailidis, Eleftherios, Bruno Marchand, Eiichi Kodama, et al.. (2009). Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-fluoro-2′-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor. Journal of Biological Chemistry. 284(51). 35681–35691. 112 indexed citations

Hattori, Shin-ichiro, Hirotomo Nakata, Hideki Harada, et al.. (2009). Potent Activity of a Nucleoside Reverse Transcriptase Inhibitor, 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine, against Human Immunodeficiency Virus Type 1 Infection in a Model Using Human Peripheral Blood Mononuclear Cell-Transplanted NOD/SCID Janus Kinase 3 Knockout Mice. Antimicrobial Agents and Chemotherapy. 53(9). 3887–3893. 43 indexed citations

Kawamoto, Atsushi, Eiichi Kodama, Stefan G. Sarafianos, et al.. (2008). 2′-Deoxy-4′-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants. The International Journal of Biochemistry & Cell Biology. 40(11). 2410–2420. 99 indexed citations

Ali, Hamed I., Noriyuki Ashida, & Tomohisa Nagamatsu. (2007). Antitumor studies. Part 3: Design, synthesis, antitumor activity, and molecular docking study of novel 2-methylthio-, 2-amino-, and 2-(N-substituted amino)-10-alkyl-2-deoxo-5-deazaflavins. Bioorganic & Medicinal Chemistry. 15(19). 6336–6352. 29 indexed citations

Ali, Hamed I., Noriyuki Ashida, & Tomohisa Nagamatsu. (2007). Antitumor studies. Part 4: Design, synthesis, antitumor activity, and molecular docking study of novel 2-substituted 2-deoxoflavin-5-oxides, 2-deoxoalloxazine-5-oxides, and their 5-deaza analogs. Bioorganic & Medicinal Chemistry. 16(2). 922–940. 39 indexed citations

Ali, Hamed I., Eiichi Akaho, Hiroto Kambara, et al.. (2006). Antitumor studies. Part 1: Design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents. Bioorganic & Medicinal Chemistry. 15(1). 242–256. 52 indexed citations

10.

Kohgo, Satoru, Kohei Yamada, Kenji Kitano, et al.. (2004). Design, Efficient Synthesis, and Anti‐HIV Activity of 4′‐C‐Cyano‐ and 4′‐C‐Ethynyl‐2′‐deoxy Purine Nucleosides. Nucleosides Nucleotides & Nucleic Acids. 23(4). 671–690. 39 indexed citations

11.

Haraguchi, Kazuhiro, Hiromichi Tanaka, Hiroyuki Hayakawa, et al.. (2004). Synthesis and antiviral activities of 1′-carbon-substituted 4′-thiothymidines. Bioorganic & Medicinal Chemistry. 12(20). 5309–5316. 14 indexed citations

12.

Yoshimura, Yuichi, Kohei Yamada, Shinji Sakata, et al.. (2000). Synthesis and biological activities of 2′-deoxy-2′-fluoro-4′-thioarabinofuranosylpyrimidine and -purine nucleosides. Bioorganic & Medicinal Chemistry. 8(7). 1545–1558. 33 indexed citations

13.

Fujiwara, Masatoshi, Noriyuki Ashida, Masayuki Okamoto, et al.. (1998). RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses. Antiviral Research. 38(2). 141–149. 6 indexed citations

14.

Satoh, Hiroshi, Yuichi Yoshimura, Noriyuki Ashida, et al.. (1998). Synthesis and Antiviral Activities of 5-Substituted 1-(2-Deoxy-2-C-methylene-4-thio-β-D-erythro-pentofuranosyl)uracilst. Nucleosides Nucleotides & Nucleic Acids. 17(1). 65–79. 11 indexed citations

15.

Manfredini, Stefano, P. G. BARALDI, Rita Bazzanini, et al.. (1998). Enzymatic Synthesis of 2′-O-acyl Prodrugs of 1-(β-D-arabinofuranosyl)-5(E)-(2-bromovinyl)uracil and of 2′-O-acyl-araU, -araC and -araA. Antiviral chemistry & chemotherapy. 9(1). 25–31. 6 indexed citations

16.

Shuto, Satoshi, et al.. (1996). Nucleosides and Nucleotides, Part 144 Synthesis and Antiviral Activity of 5‐Substituted (2′S)‐2′‐Deoxy‐2′‐C‐Methylcytidines and ‐uridines^[1]. Archiv der Pharmazie. 329(2). 66–72. 8 indexed citations

17.

Yoshimura, Yuichi, et al.. (1995). Synthesis of (2′ S )-1-(2- C -Azidomethyl-2-deoxy and 2- C -Cyanomethyl-2-deoxy-β-D-arabinofuranosyl)cytosines. Nucleosides and Nucleotides. 14(3-5). 427–429. 8 indexed citations

18.

Ashida, Noriyuki, et al.. (1994). In vitro and in vivo anti-herpes viral activities and biological properties of CV-araU. Antiviral Research. 25(3-4). 179–184. 1 indexed citations

19.

Ashida, Noriyuki, et al.. (1993). Topical treatment with BV-araU of immunosuppressed and immunocompetent shaved mice cutaneously infected with herpes simplex virus type 1. Antiviral Research. 21(1). 47–57. 5 indexed citations

20.

Ashida, Noriyuki, et al.. (1993). Metabolism of 5′-ether prodrugs of 1-β-d-Arabinofuranosyl-E-5-(2-bromovinyl)uracil in rats. Biochemical Pharmacology. 46(12). 2201–2207. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact